| 000 | 07729cam a2200781Mi 4500 | ||
|---|---|---|---|
| 001 | ocn979762083 | ||
| 003 | OCoLC | ||
| 005 | 20240925164308.0 | ||
| 006 | m d | ||
| 007 | cr ||||||||||| | ||
| 008 | 151029s2015 gw ob 000 0 eng d | ||
| 040 |
_aDEGRU _beng _erda _cDEGRU _dGBVCP _dDEBBG _dOCLCQ _dUIU _dN$T |
||
| 019 |
_a933565072 _a992902302 |
||
| 020 |
_a9783110853858 _q(electronic bk.) |
||
| 020 |
_a311085385X _q(electronic bk.) |
||
| 024 | 7 |
_a10.1515/9783110853858 _2doi |
|
| 035 |
_a1458768 _b(N$T) |
||
| 035 |
_a(OCoLC)979762083 _z(OCoLC)933565072 _z(OCoLC)992902302 |
||
| 050 | 4 | _aRC280.P5 | |
| 072 | 7 |
_aMED000000 _2bisacsh |
|
| 072 | 7 |
_aMED027000 _2bisacsh |
|
| 072 | 7 |
_aMED038000 _2bisacsh |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 072 | 7 |
_aMED085000 _2bisacsh |
|
| 072 | 7 |
_aHEA _x012000 _2bisacsh |
|
| 072 | 7 |
_aHEA _x020000 _2bisacsh |
|
| 072 | 7 |
_aMED _x004000 _2bisacsh |
|
| 072 | 7 |
_aMED _x101000 _2bisacsh |
|
| 072 | 7 |
_aMED _x109000 _2bisacsh |
|
| 072 | 7 |
_aMED _x029000 _2bisacsh |
|
| 072 | 7 |
_aMED _x040000 _2bisacsh |
|
| 072 | 7 |
_aMED _x092000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.99/247 _223 |
| 049 | _aMAIN | ||
| 245 | 0 | 0 |
_aProlactinomas : _bAn interdisciplinary approach : Proceedings of the International Symposium on Prolactinomas Graz (Austria), April 29 - May 2, 1984 / _cedited by L.M. Auer, G. Leb, G. Tscherne, W. Urdl, G.F. Walter. |
| 264 | 1 |
_aBerlin ; _aBoston : _bDe Gruyter, _c[2015] |
|
| 264 | 4 | _c©1985 | |
| 300 | _a1 online resource (439 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and indexes. | ||
| 505 | 0 | 0 |
_tFrontmatter -- _tPreface -- _tContents -- _tI. Morphology -- _tStructure and ultrastructure of prolactinomas -- _tProlactinomas and mixed adenomas with prolactin cells: an immunohistochemical study of the subcellular localization of hormones -- _tImmunocytochemical, chemical and nuclear-DNA studies of pituitary tumours -- _tHyperplasia of prolactin pituitary cells with or with out microadenoma -- _tHormone-secretion in cell culture of microprolacti nomas, periadenomatous tissue and capsules -- _tImmunocytochemical, ultrastructural and culture characteristics of prolactin-secreting pituitary adenomas -- _tImmunohìstochemical hormone determinations in pituitary adenomas in comparison with endocrinological findings in vivo -- _tNew immunocytochemical observations in prolactinomas -- _tProblematic divergencies between clinical and immunocytochemical findings in prolactinomas -- _tNecrosis of prolactinoma cells after bromocriptine treatment -- _tSpontaneous pituitary lesions and plasma prolactin levels in rats -- _tII. Radiology -- _tCT-findings in pituitary adenomas -- _tComparative study of normal subjects and cases with microadenoma on high-resolution computed tomography -- _tIII. Endocrinological and clinical aspects -- _tActions of dopamine receptor agonists at the pituitary level -- _tDopamine and prolactinomas -- _tRhythmometric study of the circadian profile of plasma prolactin in patients with prolactinoma or empty sella syndrome -- _tProlactin responses to thyrotropin-releasing hormone, metoclopramide and insulin-induced hypoglycaemia in hyperprolactinaemic and normoprolactinaemic patients -- _tEvidence for functional impairment of growth hormone secretion in prolactinoma -- _tTSH response to dopamine receptor blockade in women with PRL-secreting microadenoma: Long effect of surgical removal -- _tProlactin and TSH responses to TRH and domperidone in delayed puberty -- _tAnterior pituitary function in patients with prolactinomas -- _tPituitary adenomas with hyperprolactinaemia in males -- _tProlactinoma in multiple endocrine neoplasia type I -- _tRecurrence of hyperprolactinaemia detected in long-term follow-up of surgically normalized microprolactinomas -- _tImpairment of pituitary hormone secretion in patients with prolactinoma -- _tIV. Surgical treatment -- _tThe recurrence of pituitary adenoma -- a management challenge -- _tTranssphenoidal operations for prolactinomas -- _tProlactinomas: surgical results in 96 cases -- _tEffect of transsphenoidal surgery on pituitary function -- _tTranssphenoidal microsurgical treatment of 77 prolactinomas -- _tReview of 56 prolactin-secreting pituitary adenomas -- _tThe effect of transsphenoidal selective microadenomectomy on patients with prolactinomas -- _tSurgical results and long-term follow-up in female and male prolactinomas -- _tOtoliquorrhoea in large prolactinomas. Pathomechanism and surgical management -- _tInvasive prolactinomas in adolescents -- _tResidual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas -- _tLong-term follow-up of prolactinomas. Clinical and morphologic correlation -- _tClinicopathologîcal and neurosurgical comparative analysis of operated recurrent prolactinomas and non-secreting chromophobe pituitary adenomas -- _tV. Pharmacotherapy -- _tNew aspects of medical treatment of prolactinomas -- _tConservative management of prolactinoma -- _tEffect of bromocriptine therapy on large prolactinomas -- _tMacroprolactinomas in male patients: efficiency of treatment with a new dopaminergic drug (CU 32-085-Sandoz), tumour calcification and relative significance of preoperative tumour volume regression as estimated by CT-scan -- _tEvidence for spontaneous tumour shrinkage in a 45-year-old patient with a 20-year history of untreated microprolactinoma -- _tThe influence of various forms of treatment on serum levels of prolactin, growth hormone and insulin-like growth factors I and II in patients with hyperprolactinaemia and acromegaly -- _tPersisting partial suppression of growth hormone excess in acromegaly after long term treatment with bromocriptine -- _tMedical and surgical treatment of micro and macroprolactinomas: seven years follow-up of 65 cases -- _tVI. Aspects of gynecology and obstetrics -- _tManagement of prolactinomas in pregnancy -- _tLong-term follow-up of hyperprolactinaemia in women -- _tProphylactic bromocriptine treatment during pregnancy of women with macroprolactinomas: report of thirteen pregnancies -- _tNatural regression after pregnancy of a CT visualized microprolactinoma -- _tProlactin levels and ovarian function after surgical treatment of prolactinomas -- _tPregnancies after treatment of prolactinomas: course and complications -- _tPsychosomatic findings in patients with elevated prolactin -- _tList of contributors -- _tAuthors' index -- _tSubject index. |
| 590 | _aMaster record variable field(s) change: 050, 082, 650 | ||
| 650 | 0 |
_aProlactinoma _vCongresses. _9853879 |
|
| 650 | 4 |
_aInternal Medicine, other. _91022591 |
|
| 650 | 4 | _aInternal Medicine. | |
| 650 | 4 |
_aMedicine. _92865 |
|
| 650 | 7 |
_aHEALTH & FITNESS / Holism _2bisacsh _9175136 |
|
| 650 | 7 |
_aHEALTH & FITNESS / Reference _2bisacsh _9175137 |
|
| 650 | 7 |
_aMEDICAL / Alternative Medicine _2bisacsh _9189147 |
|
| 650 | 7 |
_aMEDICAL / Atlases _2bisacsh _9189148 |
|
| 650 | 7 |
_aMEDICAL / Essays _2bisacsh _9189149 |
|
| 650 | 7 |
_aMEDICAL / Family & General Practice _2bisacsh _9189150 |
|
| 650 | 7 |
_aMEDICAL / Holistic Medicine _2bisacsh _9189151 |
|
| 650 | 7 |
_aMEDICAL / Osteopathy _2bisacsh _9189152 |
|
| 655 | 4 |
_aElectronic books. _9396 |
|
| 700 | 1 |
_aAuer, Ludwig M. _9853881 |
|
| 700 | 1 |
_aLeb, Georg. _9853882 |
|
| 700 | 1 |
_aTscherne, Gerhard. _9853883 |
|
| 700 | 1 |
_aUrdl, Wolfgang. _9853884 |
|
| 700 | 1 |
_aWalter, Gerhard F. _9853885 |
|
| 776 | 0 | 8 |
_iPrint version: _z9783110101539 |
| 856 | 4 | 0 |
_3EBSCOhost _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=1458768 |
| 938 |
_aDe Gruyter _bDEGR _n9783110853858 |
||
| 938 |
_aEBSCOhost _bEBSC _n1458768 |
||
| 994 |
_a92 _bN$T |
||
| 999 |
_c711649 _d711649 |
||